USCAP Updates of the WHO Classification of Brain and Pituitary Tumors 2024

Overview

USCAP Updates of the WHO Classification of Brain and Pituitary Tumors 2024 presents a comprehensive, case-based review of the molecular and morphological diagnostic criteria for brain and pituitary gland tumors according to the latest 2021 and 2022 WHO classifications. This course covers substantial changes in taxonomy, nomenclature, grading, and new tumor entities, providing relevant diagnostic frameworks for both pediatric and adult central nervous system tumors.

On-demand neuropathology education — accessible anytime, anywhere.

Agenda

This course features expert-led sessions designed to enhance understanding of the updated classification systems and their practical application in daily pathological practice.

• Sellar Region Tumors 1 (Neuroendocrine) — Sylvia L. Asa, MD, PhD
• Diffuse Gliomas — Arie Perry, MD
• Sellar Region Tumors 2 (Non-Neuroendocrine) — Sylvia L. Asa, MD, PhD
• Meningiomas and Mesenchymal Tumors — Arie Perry, MD
• Ependymal and CNS Embryonal Neoplasms — Daniel Brat, MD, PhD
• Nerve Sheath and Melanocytic Tumors — Melike Pekmezci, MD
• Circumscribed Glial and Glioneuronal Tumors — Daniel Brat, MD, PhD
• Genetic Tumor Syndromes of the Nervous System — Melike Pekmezci, MD

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Apply the 2021 CNS WHO taxonomy, nomenclature, grading, and classification of adult-type diffuse gliomas.
• Integrate morphologic and molecular diagnostic techniques to diagnose pediatric-type diffuse low- and high-grade gliomas.
• Explain the role of integrated molecular diagnosis and histological criteria in the classification of other CNS tumors including ependymal, dural-based, nerve sheath, and CNS embryonal tumors.
• Summarize the newly described tumor types and subtypes in the 2021 CNS WHO classification.
• Apply the 2022 WHO classification of pituitary neuroendocrine tumors (PitNETs) by cell lineage and cell type.
• Discuss non-neuroendocrine tumors of the sellar region.
• List common nervous system tumors and associated clinical scenarios that should raise suspicion for genetic tumor syndromes.

Speakers

• Sylvia L. Asa, MD, PhD
• Arie Perry, MD
• Daniel Brat, MD, PhD
• Melike Pekmezci, MD

This course is a collaboration between the American Association of Neuropathologists and USCAP.

Target Audience

Practicing academic and community pathologists, as well as pathologists-in-training, seeking to update their expertise in brain and pituitary tumor classification and diagnostics.

Why This Topic Matters

The USCAP Updates of the WHO Classification of Brain and Pituitary Tumors 2024 supports neuropathologists in incorporating the latest WHO diagnostic criteria into clinical practice, reflecting advances in molecular techniques and tumor classification. Staying current with these changes enhances diagnostic accuracy and clinical communication within neuropathology.

MedHub Central offers this on-demand course to strengthen pathologists’ understanding of evolving neuropathology standards and support professional expertise in neurological tumor diagnostics.